✦ LIBER ✦

Naive CD8+ T cells from ART respond to primary vaccination against autologous HIV-1 antigen

✍ Scribed by Smith, Kellie N; Mailliard, Robbie B; Jiang, Weimin

Book ID: 115022293
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 221 KB
Volume: 9
Category: Article
ISSN: 1742-4690
DOI: 10.1186/1742-4690-9-s1-p16

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P17-21. Using ubiquitin fusion to augmen

P17-21. Using ubiquitin fusion to augment CD8+ T cell immune responses against HIV-1 antigens

✍ T Papagatsias, T Athanasopoulos, A Meiser, A Benlahrech, F Li, S Self… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 66 KB

CD31 (PECAM-1) is a marker of recent thy

CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or γδ T-cells, in HIV patients responding to ART

✍ Tanaskovic, Sara; Fernandez, Sonia; Price, Patricia; Lee, Silvia; French, Martyn 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 611 KB

Priming and stimulation of hepatitis C v

Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine

✍ Li, W.; Krishnadas, D. K.; Kumar, R.; Tyrrell, D. L. J.; Agrawal, B. 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 825 KB

Fusion of a cell penetrating peptide fro

Fusion of a cell penetrating peptide from HIV-1 TAT to the Theileria parva antigen Tp2 enhances the stimulation of bovine CD8+ T cell responses

✍ Alex N. Tinega; Roger Pellé; Simon Kang’a; Michael M. Gicheru; Evans L.N. Tarach 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 513 KB

Vaccination with a Fusion Protein That I

Vaccination with a Fusion Protein That Introduces HIV-1 Gag Antigen into a Multitrimer CD40L Construct Results in Enhanced CD8+ T Cell Responses and Protection from Viral Challenge by Vaccinia-Gag

✍ Gupta, S.; Termini, J. M.; Raffa, F. N.; Williams, C.-A.; Kornbluth, R. S.; Ston 📂 Article 📅 2013 🏛 American Society for Microbiology 🌐 English ⚖ 1014 KB

Balancing safety and immunogenicity in l

Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. “Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice”

✍ Michelle H. Larsen; William R. Jacobs; Steven A. Porcelli; John Kim; Uma Devi K. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 108 KB